Abstract
The glycan portion of macrolide antibiotics modulates their efficacy. High-level expression of three macrolide GTs and kinetic analysis has revealed a highly selective synthetic “tool kit” with such plasticity that 12 glycan-modified macrolide antibiotics have been readily created. One of these (1-Gal) is enhanced over its parent oleandomycin (1) by “glycotargeting”, allowing higher uptake through active internalization by virtue of the attachment of a glycan (Gal) not normally found on 1. Subsequent release of the targeting glycan by endogenous galactosidase activity releases 1.
| Original language | Undefined |
|---|---|
| Pages (from-to) | 9336-9337 |
| Number of pages | 2 |
| Journal | Journal of the American Chemical Society |
| Volume | 127 |
| Issue number | 26 |
| DOIs | |
| Publication status | Published - 11 Jun 2005 |
Research Beacons, Institutes and Platforms
- Manchester Institute of Biotechnology